Streamlining the complex process from sleep apnea diagnosis to treatment using digital health platforms meets shared mission of addressing the growing and undermanaged sleep apnea epidemic CAESAREA, Israel , April 06, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd.

CAESAREA, Israel, March 20, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq:  ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today released the following

- Record  Fourth Quarter 2019 Revenues Increase 48% to $9.8 Million  -   - Reaffirms Full Year 2020 Revenue Guidance of between $39.5 Million and $42.0 Million - - Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT -   CAESAREA, Israel, March 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical

Study will evaluate how raw signals from tens of thousands of WatchPAT recordings conducted over the last 10 years in combination with health medical records can be leveraged to predict cardiovascular outcomes CAESAREA, Israel, March 02, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd.

CAESAREA, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, announced today that it will

CAESAREA, Israel, February 18, 2020 — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced publication of results of the

CAESAREA, Israel, February 4, 2020 — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the closing of its upsized

CAESAREA, Israel, January 30, 2020 — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the upsizing and pricing of its

CAESAREA, Israel, January 28, 2020 — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed

-  2019 Fiscal Year Revenues Expected to Increase 29% to $31.1 Million to $31.3 Million  - - Full Year 2020 Revenue Guidance of $39.5 Million to $42.0 Million - CAESAREA, Israel, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a company that develops, manufactures